Completed

Autologous Amniotic Fluid Injection for Cesarean Scar Healing in High-Risk Population

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being tested

autologous amniotic fluid

+ No amniotic fluid injected in skin edges

BiologicalOther
Who is being recruted

From 30 to 45 Years
+9 Eligibility Criteria
See all eligibility criteria
How is the trial designed

Supportive Care Study

Phase 4
Interventional
Study Start: February 2024
See protocol details

Summary

Principal SponsorKasr El Aini Hospital
Last updated: January 28, 2026
Sourced from a government-validated database.Claim as a partner

Study start date: February 16, 2024

Actual date on which the first participant was enrolled.

This study focuses on improving the healing process of scars from cesarean sections in individuals considered to be at high risk. The research explores whether injecting a person's own amniotic fluid into the scar area can enhance healing. This is important because better scar healing could reduce complications and improve recovery times for mothers after childbirth by cesarean section. Participants in the study receive an injection of their own amniotic fluid into the cesarean scar area. The healing of the scar is then monitored over a period of six weeks. Observations take place at one, two, and six weeks after the injection to evaluate the scar's color, thickness, flexibility, and any fluid discharge. This helps determine how well the scar is healing and whether the amniotic fluid injections offer any benefits.

Official TitleEfficiency of Autologous Amniotic Fluid Injection in the Healing of Cesarean Section Scar in High-Risk Population
NCT06531356
Principal SponsorKasr El Aini Hospital
Last updated: January 28, 2026
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

108 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Supportive Care Study

These studies explore ways to improve comfort and daily life for people living with a condition. They may focus on easing symptoms, reducing treatment side effects, or supporting overall well-being.

Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Criteria

Female

Biological sex of participants that are eligible to enroll.

From 30 to 45 Years

Range of ages for which participants are eligible to join.

Healthy volunteers not allowed

If individuals who are healthy and do not have the condition being studied can participate.

Criteria

5 inclusion criteria required to participate
Age > 30 years old.
Anemic patients
Maternal chronic disease e.g., Diabetes and Hypertension
BMI of > 25 Kg/m2.
Show More Criteria
4 exclusion criteria prevent from participating
Rupture of membrane.
No previous section.
Anhydraminos.
Congenital malformation of the fetus.

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Treatment Groups
Study Objectives

2 intervention groups are designated in this study

This study does not include a placebo group 

Treatment Groups

Group I

Experimental

Group II

Active Comparator

Study Objectives

Primary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 1 location

Suspended

kasr Al Aini, Faculty of Medicine, Cairo University

Cairo, EgyptOpen kasr Al Aini, Faculty of Medicine, Cairo University in Google Maps
CompletedOne Study Center